A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
IDEAYA Biosciences
Debiopharm International SA
Orano Med LLC
Bayer
Beijing Biotech
A2 Biotherapeutics Inc.
DualityBio Inc.
Calico Life Sciences LLC
SciTech Development, Inc.
Incyte Corporation
Second Life Therapeutics
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Biogen
A2 Biotherapeutics Inc.
Faeth Therapeutics
Biomea Fusion Inc.
Bristol-Myers Squibb
Anaveon AG
Molecular Templates, Inc.
Mundipharma Research Limited
Aurigene Discovery Technologies Limited
Pfizer
Rain Oncology Inc
Kiadis Pharma
Lumos Pharma
AbbVie
NKGen Biotech, Inc.
Incyte Corporation
Clovis Oncology, Inc.
Clovis Oncology, Inc.
Lumos Pharma
Celgene
Clovis Oncology, Inc.
Daiichi Sankyo
Clovis Oncology, Inc.
Halozyme Therapeutics
Medtronic - MITG
MEI Pharma, Inc.
Sanofi
Cellectar Biosciences, Inc.
Bristol-Myers Squibb
GlaxoSmithKline
Eli Lilly and Company
Precision Therapeutics
Sanofi
Pharmacyclics LLC.
Poniard Pharmaceuticals